Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil versus intravenous lidocaine for blunting hemodynamic response to laryngoscopy and tracheal intubation in limb surgery
IRCT20200501047255N1Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in None comparing Remifentanil with Lidocaine (2 arms). Primary endpoints: Blood pressure and Pulse rate. Started May 2020; status: completed.
02
Drugs
remifentanillidocaine
Beyond the preview
Go deeper on IRCT20200501047255N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200501047255N1.